BUZZ-Phathom Pharmaceuticals 在宣布股票募集计划后下跌

路透中文

Jan 08

BUZZ-<a href="https://laohu8.com/S/PHAT">Phathom Pharmaceuticals</a> 在宣布股票募集计划后下跌

1月7日 - ** Phathom Pharmaceuticals PHAT.O计划增发股票，盘后股价下跌10.1%，报16.25美元。

** 专注于胃肠道() 疾病的生物制药公司宣布在 (link) 发行股票和预先筹资的认股权证；交易规模未披露

** 公司打算将募集资金净额用于一般企业用途，包括营运资金、商业化和研发支出。

** Guggenheim 和 Cantor Fitzgerald 联合账簿管理人

** 该公司还表示，预计 (link) 第四季度净收入约为 5700-5800 万美元，截至 12 月 31 日的现金约为 1.3 亿美元。

** 已发行股票约为 7110 万股，市值约为 13 亿美元。

** PHAT 股价周三上涨 10.4%，报 18.08 美元，2026 年初上涨 9%。2025 年股价大约翻了一番

** 10位分析师中有9位将该股评为 "强力买入 "或 "买入"，1位 "持有"；根据LSEG数据，PT中值为23美元。

(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2601814183"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2601814183\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2601814183?lang=en_US&edition=fundamental","thumbnail":"","is_english":false,"pubTime":"2026-01-08 05:55","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2601814183","market":"hk","top_or_hot":-1,"title":"BUZZ-Phathom Pharmaceuticals 在宣布股票募集计划后下跌","media":"路透中文","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-<a href=\"https://laohu8.com/S/PHAT\">Phathom Pharmaceuticals</a> 在宣布股票募集计划后下跌</title></head><body><p><span>1月7日</span><span> - </span>** Phathom Pharmaceuticals <span>PHAT.O</span>计划增发股票，盘后股价下跌10.1%，报16.25美元。</p><p>** 专注于胃肠道() 疾病的生物制药公司宣布在 (link) 发行股票和预先筹资的认股权证；交易规模未披露</p><p>** 公司打算将募集资金净额用于一般企业用途，包括营运资金、商业化和研发支出。</p><p>** Guggenheim 和 Cantor Fitzgerald 联合账簿管理人</p><p>** 该公司还表示，预计 (link) 第四季度净收入约为 5700-5800 万美元，截至 12 月 31 日的现金约为 1.3 亿美元。</p><p>** 已发行股票约为 7110 万股，市值约为 13 亿美元。</p><p>** PHAT 股价周三上涨 10.4%，报 18.08 美元，2026 年初上涨 9%。2025 年股价大约翻了一番</p><p>** 10位分析师中有9位将该股评为 \"强力买入 \"或 \"买入\"，1位 \"持有\"；根据LSEG数据，PT中值为23美元。</p><p>(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BUZZ-Phathom Pharmaceuticals 在宣布股票募集计划后下跌</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBUZZ-Phathom Pharmaceuticals 在宣布股票募集计划后下跌\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1098195322\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">路透中文 </p>\n<p class=\"h-time\">2026-01-08 05:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BUZZ-<a href=\"https://laohu8.com/S/PHAT\">Phathom Pharmaceuticals</a> 在宣布股票募集计划后下跌</title></head><body><p><span>1月7日</span><span> - </span>** Phathom Pharmaceuticals <span>PHAT.O</span>计划增发股票，盘后股价下跌10.1%，报16.25美元。</p><p>** 专注于胃肠道() 疾病的生物制药公司宣布在 (link) 发行股票和预先筹资的认股权证；交易规模未披露</p><p>** 公司打算将募集资金净额用于一般企业用途，包括营运资金、商业化和研发支出。</p><p>** Guggenheim 和 Cantor Fitzgerald 联合账簿管理人</p><p>** 该公司还表示，预计 (link) 第四季度净收入约为 5700-5800 万美元，截至 12 月 31 日的现金约为 1.3 亿美元。</p><p>** 已发行股票约为 7110 万股，市值约为 13 亿美元。</p><p>** PHAT 股价周三上涨 10.4%，报 18.08 美元，2026 年初上涨 9%。2025 年股价大约翻了一番</p><p>** 10位分析师中有9位将该股评为 \"强力买入 \"或 \"买入\"，1位 \"持有\"；根据LSEG数据，PT中值为23美元。</p><p>(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"PHAT","symbol_name":"Phathom Pharmaceuticals","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nL4T3Y81L9:1","article_id":"2601814183","we_media_id":"1098195322","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2601814183","pubTimestamp":1767822909,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"路透中文","introduction":"路透中文","home_visible":1,"id":"1098195322","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BUZZ-Phathom Pharmaceuticals 在宣布股票募集计划后下跌1月7日 - ** Phathom Pharmaceuticals PHAT.O计划增发股票，盘后股价下跌10.1%，报16.25美元。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"PHAT":"Phathom Pharmaceuticals","BK4007":"制药"},"translate_title":"BUZZ-Phathom Pharmaceuticals Falls After Announcing Plans for Stock Raising","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PHAT":0.9},"content_text":"BUZZ-Phathom Pharmaceuticals 在宣布股票募集计划后下跌1月7日 - ** Phathom Pharmaceuticals PHAT.O计划增发股票，盘后股价下跌10.1%，报16.25美元。** 专注于胃肠道() 疾病的生物制药公司宣布在 (link) 发行股票和预先筹资的认股权证；交易规模未披露** 公司打算将募集资金净额用于一般企业用途，包括营运资金、商业化和研发支出。** Guggenheim 和 Cantor Fitzgerald 联合账簿管理人** 该公司还表示，预计 (link) 第四季度净收入约为 5700-5800 万美元，截至 12 月 31 日的现金约为 1.3 亿美元。** 已发行股票约为 7110 万股，市值约为 13 亿美元。** PHAT 股价周三上涨 10.4%，报 18.08 美元，2026 年初上涨 9%。2025 年股价大约翻了一番** 10位分析师中有9位将该股评为 \"强力买入 \"或 \"买入\"，1位 \"持有\"；根据LSEG数据，PT中值为23美元。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":true,"code":"91000000","status":"200"}}}